Epidemiological differences among pneumococcal serotypes

Lancet Infectious Diseases

Volumn 5, Issue 2, 2005, Pages 83-93

  Hausdorff, William P ^a   Feikin, Daniel R ^b   Klugman, Keith P ^c,d  

^a GLAXOSMITHKLINE   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c EMORY UNIVERSITY   (United States)

^d Med Res Cncl/Natl Inst C   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ADULTHOOD; AGE; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; CHILD HOSPITALIZATION; CLINICAL TRIAL; DRUG FORMULATION; EPIDEMIC; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEALTH PROGRAM; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOLOGY; INCIDENCE; INFANCY; MORTALITY; NASOPHARYNX; NONHUMAN; PEDIATRICS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SYNDROME;

EID: 12944326295     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70083-9     Document Type: Review

References (143)

1. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2:2002;25-32
2. Fedson DS, Scott JAG. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine. 17:(suppl 1):1999;S11-S18
3. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 30:2000;100-121
4. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 348:2003;1737-1746
5. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol. 33:1995;2759-2762
6. Sleeman K, Knox K, George R, et al. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis. 183:2001;239-246
7. Fraser D, Givon-Lavi N, Bilenko N, Dagan R. A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice. Clin Infect Dis. 33:2001;421-427
8. Heffron R. Pneumonia with special reference to pneumococcus lobar pneumonia. 1939;The Commonwealth Fund, New York
9. Hollingshead SK, Briles DE. Streptococcus pneumoniae: new tools for an old pathogen. Curr Opin Microbiol. 4:2001;71-77
10. Taha MK, Deghmane AE, Antignac A, Zarantonelli ML, Larribe M, Alonso JM. The duality of virulence and transmissibility in Neisseria meningitidis. Trends Microbiol. 10:2002;376-382
11. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 187:2003;1424-1432
12. Sandgren A, Sjostrom K, Olsson-Liljequist B, et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis. 189:2004;785-796
13. Brueggemann AB, Spratt BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol. 41:2003;4966-4970
14. Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease protential of Streptococcus pneumoniae in children. J Infect Dis. 190:2004;1203-1211
15. Fedson DS, Musher DM, Eskola J. Pneumococcal vaccine. Plotkin SA, Orenstein WA. Vaccines. 1999;WB Saunders Company, Philadelphia, USA
16. Austrian R. Epidemiology of pneumococcal capsular types causing pediatric infections. Ped Infect Dis J. 8:(suppl):1989;S21-S22
17. Hsieh YC, Hsueh PR, Lu CY, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis. 38:2004;830-835
18. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 4:2004;144-154
19. Feikin DR, Davis M, Nwanyanwu OC, et al. Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children. Pediatr Infect Dis J. 22:2003;564-567
20. Rusen ID, Fraser-Roberts L, Slaney L, et al. Nasopharyngeal pneumococcal colonization among Kenyan children: antibiotic resistance, strain types and associations with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 16:1997;656-662
21. Syrogiannopoulos GA, Katopodis GD, Grivea IN, Beratis NG. Antimicrobial use and serotype distribution of nasopharyngeal Streptococcus pneumoniae isolates recovered from Greek children younger than 2 years old. Clin Infect Dis. 35:2002;1174-1182
22. Yagupsky P, Porat N, Fraser D, et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis. 177:1998;1003-1012
23. Jebaraj R, Cherian T, Raghupathy P, et al. Nasopharyngeal colonization of infants in southern India with Streptococcus pneumoniae. Epidemiol Infect. 123:1999;383-388
24. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact of nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 180:1999;1171-1176
25. Smith T, Lehmann D, Montgomery J, Gratten M, Riley ID, Alpers MP. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect. 111:1993;27-39
26. Scott JA, Hall AJ, Hannington A, et al. Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin Infect Dis. 27:1998;1442-1450
27. Dagan R, Givon-Lavi N, Bar-Ziv J, Porat N. The association of nasopharyngeal (NP) S. pneumoniae (Pnc) serotypes with community-acquired alveolar pneumonia (CAAP) determined by WHO standardization of interpretation of chest radiographs in children (WHO-SICR). 4th International Symposium on Pneumococci and Pneumococcal Diseases; Helsinki, Finland; May 9-13, 2004. Abstract 44.
28. Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis. 35:2002;547-555
29. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Eng J Med. 343:2000;1917-1924
30. Hsueh PR, Luh KT. Antimicrobial resistance in Streptococcus pneumoniae, Taiwan. Emerg Infect Dis. 8:2002;1487-1491
31. Muhlemann K, Matter HC, Tauber MG, Bodmer T. Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999. J Infect Dis. 187:2003;589-596
32. Kaplan SL, Mason EO Jr, Wald E, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 21:2002;141-147
33. Gertz RE Jr, McEllistrem MC, Boxrud DJ, et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol. 41:2003;4194-4216
34. Perez-Trallero E, Marimon JM, Iglesias L, Larruskain J. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates. Emerg Infect Dis. 9:2003;1159-1162
35. Porat N, Barkai G, Jacobs MR, Trefler R, Dagan R. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J Infect Dis. 189:2004;385-392
36. Corso A, Severina EP, Petruk VF, Mauriz YR, Tomasz A. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb Drug Resist. 4:1998;325-337
37. Gherardi G, Whitney CG, Facklam RR, Beall B. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis. 181:2000;216-229
38. Richter SS, Heilmann KP, Coffman SL, et al. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin Infect Dis. 34:2002;330-339
39. Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet. 357:2001;950-952
40. Miller E, Waight P, Efstratiou A, Brisson M, Johnson A, George R. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl. 89:2000;11-16
41. von Kries R, Hermann M, Hachmeister A, et al. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatr Infect Dis J. 21:2002;1017-1023
42. Alpern ER, Alessandrini EA, McGowan GL, Bell LM, Shaw KN. Serotype prevalence of occult pneumococcal bacteremia. Pediatrics. 108:2001;E23
43. Lagos R, Munoz A, Valenzuela MT, Heitmann I, Levine MM. Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. Pediatr Infect Dis J. 21:2002;1115-1123
44. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis. 30:2000;122-140
45. Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines. J Infect Dis. 181:2000;1322-1329
46. Doit C, Loukil C, Geslin P, Bingen E. Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children. J Clin Microbiol. 40:2002;2994-2998
47. Hausdorff WP, Yothers G, Dagan R, et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 21:2002;1008-1016
48. Tan TQ, Mason EO Jr, Wald ER, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 110:2002;1-6
49. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 34:2002;434-440
50. Buckingham SC, King MD, Miller ML. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J. 22:2003;499-504
51. Eltringham G, Kearns A, Freeman R, et al. Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol. 41:2003;521-522
52. Hardie W, Bokulic R, Garcia VF, Reising SF, Christie CDC. Pneumococcal pleural empyemas in children. Clin Infect Dis. 22:1996;1057-1063
53. Camou T, Palacio R, Di Fabio JL, Hortal M. Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations. Vaccine. 21:2003;2093-2096
54. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 60:1964;759-776
55. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St. Thomas's Hospital. BMJ. 290:1985;505-508
56. Henriques B, Kalin M, Ortqvist A, et al. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis. 182:2000;833-839
57. Kuikka A, Syrjanen J, Renkonen OV, Valtonen V. Pneumococcal bacteraemia during a recent decade. J Infect. 24:1992;157-168
58. Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptoccus pneumoniae disease revisited. BMC Infect Dis. 4:2004;21
59. Ostergaard C, Brandt C, Konradsen HB, Samuelsson S. Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis casued by 3 different Streptoccus pneumoniae serotypes: evaluation in humans and in 2 experimental models. J Infect Dis. 190:2004;1212-1220
60. McKenzie H, Reid N, Dijkhuizen RS. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteraemia. J Med Microbiol. 49:2000;361-366
61. Balakrishnan I, Crook P, Morris R, Gillespie SH. Early predictors of mortality in pneumococcal bacteraemia. J. Infect. 40:2000;256-261
62. Hemsley C, Eykyn SJ. Pneumococcal peritonitis in previously healthy adults: case report and review. Clin Infect Dis. 27:1998;376-379
63. Nielsen KR, Ejlertsen T, El-Batran S, Prag J. A five-year survey of pneumococcal peritonitis in two Danish counties-incidence, diagnosis and clinical entities. Clin Microbiol Infect. 9:2003;738-740
64. Barker JH, Musher DM, Silberman R, Phan HM, Watson DA. Genetic relatedness among nontypeable pneumococci implicated in sporadic cases of conjunctivitis. J Clin Microbiol. 37:1999;4039-4041
65. Centers for Disease Control and Prevention. Pneumococcal conjunctivitis at an elementary school - Maine, September 20 - December 6, 2002. MMWR Morb Mortal Wkly Rep. 52:2003;64-66
66. Ertugrul N, Rodriguez-Barradas MC, Musher DM, et al. BOX-polymerase chain reaction-based DNA analysis of nonserotypeable Streptococcus pneumoniae implicated in outbreaks of conjunctivitis. J Infect Dis. 176:1997;1401-1405
67. Martin M, Turco JH, Zegans ME, et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med. 348:2003;1112-1121
68. Shayegani M, Parsons LM, Gibbons WE Jr, Campbell D. Characterization of nontypable Streptococcus pneumoniae-like organisms isolated from outbreaks of conjunctivitis. J Clin Microbiol. 16:1982;8-14
69. Crum NF, Barrozo CP, Chapman FA, Ryan MA, Russell KL. An outbreak of conjunctivitis due to a novel unencapsulated Streptococcus pneumoniae among military trainees. Clin Infect Dis. 39:2004;1148-1154
70. Kaltoft MS, Zeuthen N, Konradsen HB. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: a 19-year nationwide surveillance study. Acta Paediatr Suppl. 89:2000;3-10
71. Hoffman JA, Mason EO, Schutze GE, et al. Streptococcus pneumoniae infections in the neonate. Pediatrics. 112:2003;1095-1102
72. Tapia-Morquecho LG, Aguilar-Ituarte F, Gomez-Barreto D, Munguia-De Sierra MT. Sepsis neonatal por Streptococcus pneumoniae serotipo. Bol Med Hosp Infant Mex. 57:2001;212-216
73. Gomez M, Alter S, Kumar ML, Murphy S, Rathore MH. Neonatal Streptococcus pneumoniae infection: case reports and review of the literature. Ped Infect Dis J. 18:1999;1014-1018
74. The WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. Pediatr Infect Dis J. 18:1999;S17-S22
75. Brandileone MC, de Andrade AL, Di Fabio JL, Guerra ML, Austrian R. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. J Infect Dis. 187:2003;1206-1212
76. Hausdorff WP. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr. 161:(suppl):2002;S135-S139
77. Zissis NP, Syriopoulou V, Kafetzis D, et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children. Eur J Pediatr. 163:2004;364-368
78. Serrano I, Ramirez M, the Portuguese Surveillance Group for the Study of Respiratory Pathogens, Melo-Cristino J. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy. Clin Microbiol Infect 2004; 10: 652-56.
79. O'Brien KL, Shaw J, Weatherholtz R, et al. Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996. Am J Epidemiol. 160:2004;270-278
80. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. Opportunities for prevention in the conjugate vaccine era. JAMA. 285:2001;1729-1735
81. Centers for Dieseae Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mort Wk Rep. 49:2000;RR-9
82. Ramdani-Bouguessa N, Rahal K. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolated in Algiers, Algeria. Antimicrob Agents Chemother. 47:2003;824-826
83. Paragi M, Kolman J, Kraigher A, et al. Possibility of application of new pneumococcal conjugate vaccines in children in Slovenia. Vaccine. 21:2003;4708-4714
84. Hedlund J, Sorberg M, Henriques Normark B, Kronvall G. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis. 35:2003;452-458
85. Fenoll A, Jado I, Vicioso D, Berron S, Yuste JE, Casal J. Streptococcus pneumoniae in children in Spain: 1990-1999. Acta Paediatr Suppl. 89:2000;44-50
86. Rudolph KM, Parkinson AJ, Reasonover AL, Bulkow LR, Parks DJ, Butler JC. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998. J Infect Dis. 182:2000;490-496
87. Goldblatt D, Ashton L, Southern J, et al. Immunogenicity and boosting following a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Programme and Abstracts of 4th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-4 2004); Helsinki, Finland; May 9-13, 2004. Abstract NEW-06.
88. Pilishvili T, Farley M, Vazquez M, et al. Effectiveness of heptavalent pneumococccal conjugate vaccine in children. Abstracts of 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, IL, USA; Sept 14-17, 2003. Abstract G-1079.
89. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. N Engl J Med. 342:2000;681-689
90. Gwaltney JM Jr, Sande MA, Austrian R, Hendley JO. Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis. 132:1975;62-68
91. Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 38:2004;632-639
92. Hoshino K, Watanabe H, Sugita R, et al. High rate of transmission of penicillin-resistant Streptococcus pneumoniae between parents and children. J Clin Micro. 40:2002;4357-4359
93. Colman G, Cooke EM, Cookson BD, Cooper PG, Efstratiou A, George RC. Pneumococci causing invasive disease in Britain 1982-1990. J Med Microbiol. 47:1998;17-27
94. Kyaw MH, Christie P, Clarke SC, et al. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis. 37:2003;1283-1291
95. Hedlund J, Svenson SB, Kalin M, et al. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis. 21:1995;948-953
96. Scott JAG, Hall AJ, Dagan R, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis. 22:1996;973-981
97. Hibbs JR, Douglas JM Jr, Judson FN, McGill WL, Rietmeijer CA, Janoff EN. Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994. Clin Infect Dis. 25:1997;195-199
98. Fry AM, Facklam RR, Whitney CG, Plikaytis BD, Schuchat A. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States. J Infect Dis. 188:2003;643-652
99. Crewe-Brown HH, Karstaedt AS, Saunders GL, Khoosal M, Jones N, Wasas A, Klugman KP. Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis. 25:1997;1165-1172
100. Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS. 12:1998;2177-2184
101. Buie KA, Klugman KP, von Gottberg A, et al. Gender as a risk factor for antibiotic resistance and infection with pediatric serogroups in HIV- infected and uninfected adults with pneumococcal bacteremia. J Infect Dis. 189:2004;1996-2000
102. Paul J. Royal Society of Tropical Medicine and Hygiene meeting at Mansion House, London, December 12, 1996. HIV and pneumococcal infection in Africa. Microbiological aspects. Trans R Soc Trop Med Hyg. 91:1997;632-637
103. Klugman KP. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis. 1:2001;85-91
104. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 19:2000;187-195
105. Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 349:2003;1341-1348
106. O'Brien KL, Moulton LH, Reid R, et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet. 362:2003;355-361
107. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 113:2004;443-449
108. Schuchat A, Flannery B, Heffernan R, et al. Invasive pneumococcal disease in HIV-AIDS: Has introduction of 7-valent pneumococcal conjugate vaccine (PCV-7) reduced HIV-related disease burden in the US? 4th International Symposium on Pneumococci and Pneumococcal Diseases; Helsinki, Finland; May 9-13, 2004. Abstract EPI-05.
109. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 344:2001;403-409
110. Kilpi T, Ahman H, Jokinen J, et al. Efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis. 37:2003;1155-1164
111. Hodges RG, MaCleod CM. Epidemic pneumococcal pneumonia: V. Final consideration of the factors underlying the epidemic. Am J Hyg. 44:1946;237-243
112. Lister S, Ordman D. Epidemiology of pneumonia on the Witwatersrand goldfields and prevention of pneumonia an other allied acute respiratory disease in native labourers in south Africa by means of vaccine. Publ South African Inst Med Res. 7:1935;1-81
113. Macleod CM, Hodges RG, Heidelberger M, Bernhard WG. Prevention of pneumococcal pneumonia by immunization with specific polysaccharides. J Exp Med. 82:1945;445-465
114. Nichols HJ. Lobar pneumonia problem in the army from viewpoint of the recent differentiation of types of pneumococci. Mil Surgeon. 41:1917;149-161
115. Ordman D. Pneumonia in native mine workers of the Witwatersrand goldfields. A bacterilocial and epidemilocial study. J Med Assoc South Africa. 5:1931;108-116
116. Schroder MC, Cooper G. An epidemic of colds, bronchitis and pneumonia due to type V pneumococci. J Infect Dis. 46:1930;384-392
117. Smillie WG. A study of an outbreak of type II pneumococcus pneumonia in the Veterans Administration Hospital at Bedford, Massachusetts. Am J Hyg. 24:1936;522-535
118. Smillie WG, Warnock GH, White HJ. A study of a type II pneumococcus epidemic at the state hospital at Worcester, Mass. Am J Public Health. 28:1938;293-302
119. Stillman EG. Further studies on the epidemiology of lobar pneumonia. J Exper Med. 26:1917;513-535
120. Strom A. Epidemic of croupous pneumonia caused by pneumococcus type 1. J Infect Dis. 50:1932;430-436
121. Sydenstricker VPW, Sutton AC. Epidemiological study of lobar pneumonia. Bull Johns Hopkins Hosp. 28:1917;312-315
122. Gleich S, Morad Y, Echague R, et al. Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks. Infect Control Hosp Epidemiol. 21:2000;711-717
123. Quick RE, Hoge CW, Hamilton DJ, Whitney CJ, Borges M, Kobayashi JM. Underutilization of pneumococcal vaccine in nursing homes in Washington State: report of a serotype-specific outbreak and a survey. Am J Med. 94:1993;149-152
124. Fiore AE, Iverson C, Messmer T, et al. Outbreak of pneumonia in a long-term care facility: Antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia. J Am Geriatr Soc. 46:1998;1112-1117
125. Centers for Disease Control and Prevention. Outbreaks of pneumococcal pneumonia among unvaccinated residents in chronic-care facilities - Massachusetts, October 1995, Oklahoma, February 1996, and Maryland, May-June 1996. MMWR Morb Mortal Wkly Rep. 46:1997;60-62
126. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med. 338:1998;1861-1868
127. Sheppard DC, Bartlett KA, Lampiris HW. Streptococcus pneumoniae transmission in chronic-care facilities: description of an outbreak and review of management strategies. Infect Control Hosp Epidemiol. 19:1998;851-853
128. Centers for Disease Control and Prevention. Outbreak of pneumococcal pneumonia among unvaccinated residents of a nursing home - New Jersey, April 2001. MMWR Morb Mortal Wkly Rep. 50:2001;707-710
129. Bescos JG, Ugarriza AV, Sancho CA, et al. Transmision de Streptococcus pneumoniae en una residencia de ancianos: analisis de un brote epidemico. Med Clin (Barc). 121:2003;48-52
130. Rauch AM, O'Ryan M, Van R, Pickering LK. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Tex, Day-care center. Am J Dis Child. 144:1990;923-927
131. Cherian T, Steinhoff MC, Harrison LH, Rohn D, McDougal LK, Dick J. A cluster of invasive pneumococcal disease in young children in child care. JAMA. 271:1994;695-697
132. Craig AS, Erwin PC, Schaffner W, et al. Carriage of multidrug-resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center. Clin Infect Dis. 29:1999;1257-1264
133. Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsular types and outcomes of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med. 134:1974;505-510
134. DeMaria A Jr, Browne K, Berk Sl, Sherwood EJ, McCabe WR. An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA. 244:1980;1446-1449
135. Mercat A, Nguyen J, Dautzenberg B. An outbreak of pneumococcal pneumonia in two men's shelters. Chest. 99:1991;147-151
136. Hoge CW, Reichler MR, Dominguez EA, et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med. 331:1994;643-648
137. Gratten M, Morey F, Dixon J, et al. An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia. Med J Aust. 158:1993;340-342
138. Dagan R, Gradstein S, Belmaker I, et al. An outbreak of Streptococus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis. 30:2000;319-321
139. Proulx JF, Dery S, Jette LP, Ismael J, Libman M, De Wals P. Pneumonia epidemic caused by a virulent strain of Streptococcus pneumoniae serotype 1 in Nunavik, Quebec. Can Commun Dis Rep. 28:2002;129-131
140. Crum NF, Wallace MR, Lamb CR, et al. Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. Am J Prev Med. 25:2003;107-111
141. Kim PE, Musher DM, Glezen WP, Rodriguez-Barradas MC, Nahm WK, Wright CE. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis. 22:1996;100-106
142. Konradsen HB, Kaltoft MS. Pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immun. 9:2002;358-365
143. Pedersen MK, Hoiby EA, Froholm LO, Hasseltvedt V, Lermark G, Caugant DA. Systemic pneumococcal disease in Norway 1995-2001: capsular types and antimicrobial resistance. Epidemiol Infect. 132:2004;167-175